Biolase Inc (BIOL)

Add to Watchlists
Create an Alert
1.29 +0.11  +9.32% NASDAQ Jan 17, 16:59 Delayed 2m USD

Biolase Inc Research and Development Expense (Quarterly):

1.277M for Sept. 30, 2018
View 4,000+ financial data types
View Full Chart

Biolase Inc Research and Development Expense (Quarterly) Chart

Export Data
Save Image
Print Image

Biolase Inc Historical Research and Development Expense (Quarterly) Data

View and export this data going back to 1992. Start your Free Trial
Export Data Date Range:
Data for this Date Range  
Sept. 30, 2018 1.277M
June 30, 2018 1.361M
March 31, 2018 1.289M
Dec. 31, 2017 1.389M
Sept. 30, 2017 1.601M
June 30, 2017 1.81M
March 31, 2017 1.429M
Dec. 31, 2016 2.298M
Sept. 30, 2016 1.715M
June 30, 2016 1.90M
March 31, 2016 1.886M
Dec. 31, 2015 1.75M
Sept. 30, 2015 1.756M
June 30, 2015 1.974M
March 31, 2015 1.803M
Dec. 31, 2014 1.35M
Sept. 30, 2014 1.276M
June 30, 2014 0.978M
March 31, 2014 0.973M
Dec. 31, 2013 1.042M
Sept. 30, 2013 0.977M
June 30, 2013 1.005M
March 31, 2013 1.005M
Dec. 31, 2012 1.027M
Sept. 30, 2012 1.195M
June 30, 2012 1.272M
March 31, 2012 1.19M
Dec. 31, 2011 1.073M
Sept. 30, 2011 1.052M
June 30, 2011 1.093M
March 31, 2011 1.093M
Dec. 31, 2010 0.80M
Sept. 30, 2010 0.775M
June 30, 2010 0.995M
March 31, 2010 1.22M
Dec. 31, 2009 0.945M
Sept. 30, 2009 0.999M
June 30, 2009 1.119M
March 31, 2009 1.083M
Dec. 31, 2008 1.535M
Sept. 30, 2008 1.313M
June 30, 2008 1.271M
March 31, 2008 1.461M
Dec. 31, 2007 1.418M
Sept. 30, 2007 1.279M
June 30, 2007 1.197M
March 31, 2007 1.21M
Dec. 31, 2006 0.858M
Sept. 30, 2006 1.471M
June 30, 2006 1.30M

There is no data for the selected date range.

An error occurred. Please try again by refreshing your browser or contact us with details of your problem.

About R&D Expense

R&D expenses are a line item from many companies' income statements.

R&D expense (short for research and development expense) is essentially the amount of money that a company spends to develop new products and services each year. For example, if a pharmaceutical firm hires research scientists to develop new drugs, the salaries of these researchers will generally be expensed in the R&D expense category.

Like marketing expenses, but unlike capital expenditures, R&D expenses are subtracted from revenues every year directly. Therefore, accountants treat R&D spending as an expense rather than as an investment, though there is continuous debate over whether this is the correct classification.

An investor looking at companies with large R&D expenditures should think hard about whether a single company's R&D spending is an expense (like buying rubber to produce tires) or whether it is an investment (like buying machinery to produce tires more efficiently). Determining the answer to that question can have a large impact on how the company is valued.
Learn More


BIOL Research and Development Expense (Quarterly) Benchmarks

Milestone Scientific Inc 0.0015M
American Medical Technologies Inc --
Lancer Orthodontics Inc --

BIOL Research and Development Expense (Quarterly) Range, Past 5 Years

Minimum 0.973M Mar 2014
Maximum 2.298M Dec 2016
Average 1.569M

BIOL Research and Development Expense (Quarterly) Excel Add-In Codes

  • Metric Code: r_and_d_expense
  • Latest data point: =YCP("BIOL", "r_and_d_expense")
  • Last 5 data points: =YCS("BIOL", "r_and_d_expense", -4)

To find the codes for any of our financial metrics, see our Complete Reference of Metric Codes.

Access our powerful Excel Add-in with a YCharts Professional Membership. Learn More.




Please note that this feature is only available as an add-on to YCharts subscriptions.

Please note that this feature requires full activation of your account and is not permitted during the free trial period.

Start My Free Trial {{}} No credit card required.

Already a subscriber? Sign in.